ASST Overview

Strive, Inc. is an asset management Bitcoin treasury company. The Company is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. The Company's subsidiary, Strive Asset Management, LLC, is a SEC-registered investment adviser, which has assets under management (AUM) across approximately 13 exchange-traded funds, collective investment trusts, and a direct indexing platform. In addition, the Company owns Semler Scientific, Inc., a healthcare technology subsidiary focused on early disease detection products. Through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.

Wall Street analysts forecast ASST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASST is30.00 USD with a low forecast of 30.00 USD and a high forecast of 30.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Strive Inc revenue for the last quarter amounts to 2.76M USD, increased 1516.41

Strive Inc. EPS for the last quarter amounts to -4.53 USD, increased 79.76

Strive Inc (ASST) has 28 emplpoyees as of June 18 2026.

Today ASST has the market capitalization of 1.23B USD.